Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids
Stopped early · Phase 1 · Has a placebo group
Conditions studied: Chronic Pain
In brief
The goal of this research proposal is to determine if the intraoperative administrative of Ketamine and Magnesium during laparoscopic gynecologic surgery improves postoperative pain in patients on chronic opioid therapy for management of chronic pelvic pain.
Key facts
- Study ID
- NCT02940509
- Run by
- Milton S. Hershey Medical Center
- People needed
- 20
- Starts
- 2017-07-01
- Expected to finish
- 2018-02-27
- Last updated by the study team
- 2022-05-27
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Subjects undergoing elective laparoscopic gynecologic surgery
- Patients with chronic pelvic pain defined as pain that has persisted for more than 6 months in duration which is localized to the pelvis, anterior abdominal wall, lower back or buttocks and has leads to functional disability or medical care1
- Patients requiring opioids daily for >1 month
- Consenting adults age 18-80
- American Society of Anesthesiologists (ASA) Physical Status classification II to ASA III
You may not qualify if…
- Patient refusal
- Chronic Kidney disease (Creatinine>2)
- Patients treated with methadone
- Known allergy or adverse effect of ketamine or magnesium
- Patient unable to give informed consent
- Patient with limited or no English fluency
- Uncontrolled hypertension
Where it is running
- Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.